Exocrine Pancreatic Insufficiency

Description

Exocrine pancreatic insufficiency (EPI) is a syndrome characterised by insufficient secretion of digestive enzymes by the exocrine portion of the pancreas. Most commonly EPI results following the progressive reduction in pancreatic mass caused by pancreatic acinar atrophy or chronic pancreatitis. EPI may also occur secondary to excessive gastric acid secretion (pancreatic enzyme activity affected by excess acid)or severe protein malnutrition ( decreased synthesis of pancreatic enzymes). The Pancreas has a considerable functional reserve and a large proportion needs to be non-functional to show signs of EPI. In the dog EPI is mostly caused by Pancreatic Atrophy, Exocrine or Pancreatic Acinar Atrophy (PAA). In the cat EPI is usually associated with chronic pancreatitis.

For EPI in the dog see here

For EPI in the cat see here

Signalment

• Most common in dog and particularly theses breeds:

• 

  German Shepherd (Alsatian)

  Copyright

• 

  Collie (Rough)

  Copyright Sannse 2003

• Occurs occasionally in other species including calves with pancreatic hypoplasia and in cats (chronic pancreatitis)
• In contrast, horses with very little pancreatic tissue develop hypoinsulinism but rarely EPI

Diagnosis

History

• Weight loss with or without polyphagia (usually ravenous with scavenging)
• Coprophagia and pica
• Polyuria and polydipsia due to Diabetes Mellitus
• Varible diarrhoea (large volumes of semi-formed faeces)
• Vomiting
• Borborygmus and flatulance

Clinical Signs

• Steatorrhoea
• Diarrhoea
• Mild to marked weight loss
• Muscle wastage
• Polyphagia
• Poor haircoat
• Flatulance

Laboratory Tests

Routine tests are generally unhelpful. Serum alanine aminotransferase (ALT) can have mild to moderate elevations. Other biochemical results include reductions in total lipid, polyunsaturated fatty acid concentraions and cholesterol. The most sensitive and specific test for the diagnosis of EPI is the TLI serum assay. The values are greatly reduced as compared to normal animals. Values <2µg/l in dogs and <8µg/l in cats are considered diagnostic. This test must be carried out after withdrawing food for several hours. Serum fTLI is only available from specialist laboratories. Other tests are available but are often inconvenient and expensive.

Other

Atrophy of the pancreas seen via exploratory laparotomy or laparoscopy

Treatment

Enzyme replacement

EPI can be managed with the supplementation of pancreatic enzymes from dried pancreatic extracts. Meals should be fed twice a day to allow weight gain. Many clinical signs resolve within 5 days. Doses can then be lowered to a minimum effective dose which is different for each animal. Cheaper alternatives include chopped raw cow or pig pancreas.

Dietary modification

• Diets containing high volumes of non-fermentable fibre should be avoided
• Low fat diets should not be fed
• Certain studies show that:
  • animals may do better with a highly digestible diet
  • the animals may also benefit from readily hydrolysed and absorbed medium chain triglycerides within the diet

Vitamin supplementation

Levels of vitamin B12 (cobalamin) and vitamin E (tocopherol) are often found to be low.

• Tocopherol should be supplemented for 1 month
• Cobalamin weekly for several weeks. Long term monitoring should be carried out in cats.

Antibiotic therapy

Dogs with EPI often have Small Intestinal Bacterial Overgrowth (SIBO). This can be treated with oral oxytetracycline, tylosin or metronidazole.

Glucocorticoid therapy

This is a last line treatment.

• Oral prednisolone. Long term treatment is usually not needed

Prognosis

EPI is a life-long condition and so is the treatment. However recoveries have been reported. The prognosis is generally good so long as the owner understands the longevity of the disease and the cost involved with treating it.

References

Hall, E.J, Simpson, J.W. and Williams, D.A. (2005) BSAVA Manual of Canine and Feline Gastroenterology (2nd Edition) BSAVA

Also known as:

EPI